Clinical trial
B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease
NCT02316691 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease
- Lead sponsor
- University of Pittsburgh
- Phase
- Observational
- Overall status
- Terminated
- Start date
- January 31, 2016
- Completion date
- November 30, 2019
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
thyroid eye disease